Your session is about to expire
← Back to Search
Behavioural Intervention
TabCAT Assessment for Dementia
N/A
Recruiting
Led By Katherine Possin, PhD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during the 12-month steady state period
Awards & highlights
Study Summary
This trial tests a tablet tool to detect dementia in primary care. Results will assess its accuracy and effectiveness in helping spot cognitive impairment.
Who is the study for?
This trial is for adults who have visited one of the 26 participating primary care clinics in Southern California during the study period. It's focused on those aged 65 and older for the main analysis but includes adults over 18. Children under 18 cannot participate.Check my eligibility
What is being tested?
The TabCAT Brain Health Assessment, a tablet-based tool designed to detect cognitive impairments including dementia, is being tested. The study aims to see if this user-friendly technology with automatic scoring improves detection rates in a real-world clinic setting.See study design
What are the potential side effects?
Since this trial involves an assessment tool rather than medication or invasive procedures, traditional side effects are not applicable. However, participants may experience stress or discomfort while completing cognitive tests.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ during the 12-month steady state period
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during the 12-month steady state period
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
The rate of patients with at least one cognitive impairment diagnosis documented in the medical record by any primary care provider during the 12-month steady state period at the clinic.
Secondary outcome measures
The rate of patients who have a documented standardized cognitive assessment performed in the primary care clinic within 4 months of an incident cognitive impairment diagnosis.
The rate of patients who have a referral to Geriatrics, Neurology or Psychiatry.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: TabCAT-Brain Health AssessmentExperimental Treatment1 Intervention
Primary care providers concerned that their patients are exhibiting signs of cognitive decline based on patient, informant (family), or provider concerns will refer them for a TabCAT-BHA assessment and follow-up care.
Group II: Usual CareActive Control1 Intervention
Patients in the control practices will continue with usual care workflows.
Find a Location
Who is running the clinical trial?
National Institute of Neurological Disorders and Stroke (NINDS)NIH
1,341 Previous Clinical Trials
469,589 Total Patients Enrolled
University of California, San FranciscoLead Sponsor
2,506 Previous Clinical Trials
15,058,555 Total Patients Enrolled
Kaiser PermanenteOTHER
538 Previous Clinical Trials
23,933,093 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any available openings in this clinical trial for participants?
"This clinical trial is actively seeking volunteers, as indicated on the online repository of medical studies. It was initially made public on September 15th 2023 and had its parameters most recently adjusted on October 13th 2023."
Answered by AI
How many people are partaking in this research project?
"Affirmative. Clinicaltrials.gov has the latest updates that this clinical trial, which was first announced on September 15th 2023, is in search of participants. Approximately 180 000 patients need to be enrolled from 1 medical centre."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger